Advertisement Pharmaceutical Business review - Page 170 of 5278 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
June 22, 2026

Japan approves Sanofi’s Sarclisa combo for MM treatment

Sanofi has received approval from Japan’s Ministry of Health, Labour and Welfare for its subcutaneous (SC) formulation of Sarclisa (isatuximab) in combination with standard therapies to treat multiple myeloma (MM).

Continue
Pivotal data from the IRAKLIA Phase III study showed a 71.1% ORR for Sarclisa SC-Pd via OBI. Credit: luchschenF / Shutterstock.com.
June 22, 2026

Sun Pharma to acquire Innovcare Lifesciences for $28.7m

Following the conclusion of the deal, Sun Pharma will acquire full ownership and control of Innovcare Lifesciences. Credit: Nils Versemann / Shutterstock.com.
June 19, 2026

Voro and Alloy partner on tumour-selective TCE therapeutics

The partnership aims to create immunotherapies that trigger immune responses in tumours while limiting effects on healthy tissues. Credit: TheCorgi / Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. Biogen to acquire RayThera for up to $1bn
  2. Jazz and AbCellera sign deal for T-cell engagers in solid tumours
  3. LG AI Research and D&D Pharmatech sign agreement for oral peptide drugs
  4. AviadoBio broadens vMiX gene silencing licence with King’s College London
  5. Altaris to acquire Simulations Plus in $375m all-cash deal

PRESS RELEASES

Protecting Precious Therapies: SCHOTT Pharma Unveils Polymer Syringe for Ultra-Low Temperature Storage at -180°C
Protecting Precious Therapies: SCHOTT Pharma Unveils Polymer Syringe for Ultra-Low Temperature Storage at -180°C
Pharmaceutical Business Review
Redefining Safety, Efficiency, and Sustainability: SCHOTT Pharma Launches Next-Generation Polymer Syringe System
SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography